Manuscripts
Showing 1533 manuscripts.
Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women
Citation
Mark Mirochnick, IMPAACT P1026s Protocol Team, Edmund V. Capparelli, Alice Stek, Jiajia Wang, Sandra K. Burchett, Regis Kreitchmann, Kittipong Rungruengthanakit, Kathleen George, Tim R. Cressey, Nahida Chakhtoura, Elizabeth Smith, David E. Shapiro, Anna Tran, Brookie M. Best. Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women. Journal of Acquired Immune Deficiency Syndromes. 2016. 72: 289-96. PMID: 26918544Year
2016
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S
Complications and route of delivery in a large cohort study of HIV-1-infected women - IMPAACT P1025
Citation
Alice Stek and the P1025 Team, Kunjal Patel , Ruth E. Tuomala , Gwendolyn B. Scott , Elizabeth G. Livingston , Yanling Huo. Complications and route of delivery in a large cohort study of HIV-1-infected women - IMPAACT P1025. Journal of Acquired Immune Deficiency Syndromes. 2016. 73: 74-82. PMID: 27082506Year
2016
Journal
Journal of Acquired Immune Deficiency Syndromes
Killer Cell Immunoglobulin-like Receptor Alleles Alter HIV Disease in Children
Citation
Sean S Brummel, Konstantia Angelidou, Rodney Trout, Terence Fenton, Stephen A Spector, Kumud K Singh, Min Qin. Killer Cell Immunoglobulin-like Receptor Alleles Alter HIV Disease in Children. PLoS One. 2016. 11: e0151364. PMID: 26983081Year
2016
Journal
PLoS One
Nevirapine- versus lopinavir/ritonavir-based antiretroviral therapy in HIV-infected infants and young children: long-term follow-up of the IMPAACT P1060 randomized study
Citation
Jane Lindsey, Paul Palumbo, Moherndran Archary, Benjamin H Chi, Mark Cotton, Sylvia Dittmer, Lee Fairlie, Enid Kabugho, Portia Kamthunzi, Arti Kinikar, Tapiwa Mbengeranwa, Levina Msuya, Pauline Sambo, Kunjal Patel, Emily Barr, Patrick Jean-Phillipe, Linda Barlow-Mosha, Avy Violari, Konstantia Angelidou, Lynne Mofenson. Nevirapine- versus lopinavir/ritonavir-based antiretroviral therapy in HIV-infected infants and young children: long-term follow-up of the IMPAACT P1060 randomized study. Clinical Infectious Diseases. 2016. 63: 1113-21. PMID: 27439527Year
2016
Journal
Clinical Infectious Diseases
Study
P1060
Pharmacokinetics of Unboosted Atazanavir in Treatment-Experienced HIV-infected Children, Adolescents and Young Adults
Citation
Andrew Wiznia, Marc Foca, Patrick Jean-Philipe, Bobbie Graham, Jennifer King, Paula Britto, Vincent Carey, Edward Acosta, Ram Yogev for the IMPAACT P1058A team, Tim Cressey, Rohan Hazra. Pharmacokinetics of Unboosted Atazanavir in Treatment-Experienced HIV-infected Children, Adolescents and Young Adults. Pediatric Infectious Disease Journal. 2016. 35: 1333-1335. PMID: 27583590Year
2016
Journal
Pediatric Infectious Disease Journal
Study
P1058A
Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor-Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy
Citation
Portia Kamthunzi, Patrick Duffy, Gerald Tegha, William Borkowsky for the P1068s team, Elizabeth Wills Petzold, Linda Barlow-Mosha, Ben Chi, Yonghua Li, Tiina Ilmet, Brian Kirmse, Jillian Neal, Sunil Parikh, Nagamah Deygoo, Patrick Jean Philippe, Lynne Mofenson, Roy Prescott, Charlotte Hobbs, Philippa Musoke, Erin Gabriel , Paul Palumbo. Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor-Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy. PLoS One. 2016. 11: e0165140. PMID: 27936233Year
2016
Journal
PLoS One
Study
P1068S
Cost-effectiveness of Pre-Exposure HIV Prophylaxis During Pregnancy and Breast feeding in Sub-Saharan Africa
Citation
Lynda Stranix-Chibanda, Sybil Hosek, D. Heather Watts, George Siberry, Jeffrey Stringer, Benjamin Chi, Joan Price, Stephanie Wheeler. Cost-effectiveness of Pre-Exposure HIV Prophylaxis During Pregnancy and Breast feeding in Sub-Saharan Africa. Journal of Acquired Immune Deficiency Syndromes. 2016. 1: s145-53. PMID: 27355502Year
2016
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
IMPAACT 2009
Etravirine Pharmacokinetics in HIV-Infected Pregnant Women
Citation
Brookie M Best, Edmund V Capparelli, Alice M Stek, Courtney V Fletcher, Angela Colbers, Jiajia Wang, Jose Molto, Graham Taylor, Elizabeth Smith, Carmen Hidalgo Tenorio, Nahida Chakhtoura, Marjo Van Kasteren, Mark Mirochnick, David Burger, Nikki Mulligan, Stein Schalkwijk. Etravirine Pharmacokinetics in HIV-Infected Pregnant Women. Frontiers in Pharmacology. 2016. 7: 239. PMID: 27540363Year
2016
Journal
Frontiers in Pharmacology
Study
P1026S
Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy.
Citation
Denise L Jacobsen, Isabelle Boucioran, Meei-Li Huang, Keith R Jerome, Gonzague Jourdain, Nicole Ngo-Giang-Huong, Sandra Burchett, Lisa Frenkel, Soren Gantt, Erin Leister. Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy.. Journal of Medical Virology. 2016. 88: 1051-8. PMID: 26519647Year
2016
Journal
Journal of Medical Virology
Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus
Citation
N Ngo-Giang-Huong, W Khamduang, L Laomanit, G Jourdain, L Frenkel, IA Beck, R Payant. Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus. Journal of Virological Methods. 2016. 233: 51-55. PMID: 27025356Year
2016
Journal
Journal of Virological Methods